nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A four-stage strategy to reduce childhood pneumonia-related mortality by 2015 and beyond
|
Brooks, W. Abdullah |
|
2009 |
27 |
5 |
p. 619-623 5 p. |
artikel |
2 |
An avian cell line designed for production of highly attenuated viruses
|
Jordan, Ingo |
|
2009 |
27 |
5 |
p. 748-756 9 p. |
artikel |
3 |
Augmentation of alphavirus vector-induced human papilloma virus-specific immune and anti-tumour responses by co-expression of interleukin-12
|
Riezebos-Brilman, Annelies |
|
2009 |
27 |
5 |
p. 701-707 7 p. |
artikel |
4 |
Basal and stimulus-induced cytokine expression is selectively impaired in peripheral blood mononuclear cells of newborn foals
|
Liu, Tong |
|
2009 |
27 |
5 |
p. 674-683 10 p. |
artikel |
5 |
Construction and characterization of a novel DNA vaccine that is potent antigen-specific tolerizing therapy for experimental arthritis by increasing CD4+CD25+Treg cells and inducing Th1 to Th2 shift in both cells and cytokines
|
Xinqiang, Song |
|
2009 |
27 |
5 |
p. 690-700 11 p. |
artikel |
6 |
Cost-effectiveness analysis of behavioral interventions to improve vaccination compliance in homeless adults
|
Greengold, Barbara |
|
2009 |
27 |
5 |
p. 718-725 8 p. |
artikel |
7 |
Editorial Board
|
|
|
2009 |
27 |
5 |
p. CO2- 1 p. |
artikel |
8 |
Enhancing therapeutic HPV DNA vaccine potency through depletion of CD4+CD25+ T regulatory cells
|
Chuang, Chi-Mu |
|
2009 |
27 |
5 |
p. 684-689 6 p. |
artikel |
9 |
Ethical issues in immunisation
|
Isaacs, David |
|
2009 |
27 |
5 |
p. 615-618 4 p. |
artikel |
10 |
Factors conditioning effectiveness of a reminder/recall system to improve influenza vaccination in asthmatic children
|
Esposito, Susanna |
|
2009 |
27 |
5 |
p. 633-635 3 p. |
artikel |
11 |
Human vaccine research in the European Union
|
Olesen, Ole F. |
|
2009 |
27 |
5 |
p. 640-645 6 p. |
artikel |
12 |
Immunogenicity and safety of a tetanus toxoid, reduced diphtheria toxoid and three-component acellular pertussis vaccine in adults 19–64 years of age
|
Blatter, Mark |
|
2009 |
27 |
5 |
p. 765-772 8 p. |
artikel |
13 |
MALVAC 2008: Measures of efficacy of malaria vaccines in phase 2b and phase 3 trials—Scientific, regulatory and public health perspectives
|
Moorthy, Vasee S. |
|
2009 |
27 |
5 |
p. 624-628 5 p. |
artikel |
14 |
Phenotypic and genetic diversity of the traditional Lister smallpox vaccine
|
Garcel, Aude |
|
2009 |
27 |
5 |
p. 708-717 10 p. |
artikel |
15 |
Platycodin D is a potent adjuvant of specific cellular and humoral immune responses against recombinant hepatitis B antigen
|
Xie, Yong |
|
2009 |
27 |
5 |
p. 757-764 8 p. |
artikel |
16 |
Pneumococcal seroepidemiology in Turkey
|
Erdem, Hakan |
|
2009 |
27 |
5 |
p. 629-630 2 p. |
artikel |
17 |
Preparation and characterization of an immunogenic meningococcal group A conjugate vaccine for use in Africa
|
Lee, Che-Hung |
|
2009 |
27 |
5 |
p. 726-732 7 p. |
artikel |
18 |
Prevalence of human papillomavirus types in cervical and oral cancers in central India
|
Gheit, Tarik |
|
2009 |
27 |
5 |
p. 636-639 4 p. |
artikel |
19 |
Prime–boost vaccination with a fowlpox vector and an inactivated avian influenza vaccine is highly immunogenic in Pekin ducks challenged with Asian H5N1 HPAI
|
Steensels, M. |
|
2009 |
27 |
5 |
p. 646-654 9 p. |
artikel |
20 |
Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase
|
Pavlova, Sophia P. |
|
2009 |
27 |
5 |
p. 773-785 13 p. |
artikel |
21 |
Protein prime–peptide boost as a new strategy induced an Eppin dominant B-cell epitope specific immune response and suppressed fertility
|
Chen, Zhengqiong |
|
2009 |
27 |
5 |
p. 733-740 8 p. |
artikel |
22 |
Safety, tolerability and immunogenicity of a mammalian cell-culture-derived influenza vaccine: A sequential Phase I and Phase II clinical trial
|
Groth, N. |
|
2009 |
27 |
5 |
p. 786-791 6 p. |
artikel |
23 |
Schistosoma mansoni ex vivo lung-stage larvae excretory–secretory antigens as vaccine candidates against schistosomiasis
|
Ridi, Rashika El |
|
2009 |
27 |
5 |
p. 666-673 8 p. |
artikel |
24 |
Simplifying paediatric immunization with a fully liquid DTP–HepB–Hib combination vaccine: Evidence from a comparative time-motion study in India
|
Wiedenmayer, Karin A. |
|
2009 |
27 |
5 |
p. 655-659 5 p. |
artikel |
25 |
Some guidelines for determining foot-and-mouth disease vaccine strain matching by serology
|
Mattion, Nora |
|
2009 |
27 |
5 |
p. 741-747 7 p. |
artikel |
26 |
Sulfated modification can enhance the adjuvanticity of lentinan and improve the immune effect of ND vaccine
|
Guo, Zhenhuan |
|
2009 |
27 |
5 |
p. 660-665 6 p. |
artikel |
27 |
Technology transfer hub for pandemic influenza vaccine
|
Friede, M. |
|
2009 |
27 |
5 |
p. 631-632 2 p. |
artikel |
28 |
The comparative evaluation of expanded national immunization policies in Korea using an analytic hierarchy process
|
Shin, Taeksoo |
|
2009 |
27 |
5 |
p. 792-802 11 p. |
artikel |